AstraZeneca Gets FDA Approval for Metastatic Breast Cancer Treatment Datroway
AstraZeneca said the U.S. Food and Drug Administration approved Datroway, a treatment for metastatic breast cancer developed in combination with Daiichi Sankyo.
The American Journal of Managed Care10h
FDA Approves Datopotamab Deruxtecan for HR-Positive/HER2-Negative Metastatic Breast Cancer
The approval is based on findings from the phase 3, multicenter, open-label, randomized TROPION-Breast01 trial.
Hosted on MSN14h
FDA grants breakthrough designation to PreludeDx’s DCIS test
The US Food and Drug Administration (FDA) has granted breakthrough device designation to PreludeDx's DCISionRT test, a risk ...
The Power of Personalized Breast Cancer Care
It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...
Becker's Hospital Review16h
Breast cancer rates by state
The overall average breast cancer incidence rate in the U.S. was 131.8 per 100,000 and the overall average breast cancer mortality rate was 19.3 per 100,000. Among women in the U.S., breast cancer ...
News Medical1d
New resource from NCCN offers guidance on hereditary cancer risk
Today, the National Comprehensive Cancer Network (NCCN)-an alliance of leading cancer centers-published a new resource to inform people about the latest recommendations around hereditary and familial ...
Exploring novel deep learning-based models for cancer histopathology image analysis
Histopathological evaluation of tumor specimens has long been essential in diagnosing breast cancer and guiding clinical ...
WQRF Rockford on MSN4d
Olivia Munn’s Breast Cancer Diagnosis Helps Diagnose Another
Kicking things off with Olivia Munn’s breast cancer diagnosis. Last year, Inside Correspondent Alison Hall reported on Olivia ...